Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 31.3.2023Zentiva, k.s. (ZNT-1)3734DDesurol 60 mg tvrdé kapsuly s predĺženým uvoľňovaním (cps pld 100x60 mg (fľ.HDPE))3.4.2023R
 31.3.2023Zentiva, k.s. (ZNT-1)41863Lozap H (tbl flm 30 (blis. PVC/PVDC/Al))31.3.2023R
 31.3.2023Zentiva, k.s. (ZNT-1)5802BMixor 80 mg/5 mg (tbl 28x80 mg/5 mg (blis.OPA/Al/PVC/Al))31.3.2023O
 31.3.2023Zentiva, k.s. (ZNT-1)87165Tezeo 40 mg (tbl 90x40 mg (blis.OPA/Al/PVC/Al))31.3.2023R
 31.3.2023Zentiva, k.s. (ZNT-1)93157ISOCHOL (tbl obd 30x400 mg (fľ. skl. hnedá))31.3.2023R
 31.3.2023Teva B.V. (TEV-NL-4)52119Olfen 140 mg (emp med 5x140 mg (vre.papier/PE/Al/kopol.etylénmetakryl. kys.))11.4.2022O
 31.3.2023Krewel Meuselbach GmbH (KRE)25590Regulax (cub por 18x0,71 g/0,30 g (fólia Al))31.3.2023Z
 31.3.2023Krewel Meuselbach GmbH (KRE)25584Regulax (cub por 6x0,71 g/0,30 g (fólia Al))31.3.2023Z
 31.3.2023MEDOCHEMIE Ltd. (MOE)37099ARKETIS 20 mg (tbl 30x20 mg (blis.PVC/Al))1.4.2023R
 31.3.2023MEDOCHEMIE Ltd. (MOE)41152MEDOCLAV FORTE 312,5 mg (plv sus 1x100 ml (fľ.skl.jantárová))1.4.2023O
 31.3.2023MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))1.4.2023O
 31.3.2023CSL Behring GmbH (CSL)50936Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml (liek.inj.skl.))30.3.2023R
 31.3.2023CSL Behring GmbH (CSL)80027Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x25 ml (liek.inj.skl.))30.3.2023R
 30.3.2023Chiesi Pharmaceuticals GmbH (CHS-AT)84575Otobacid N (int ots 1x5 ml (liek.skl.))31.3.2023O
 30.3.2023Immedica Pharma AB (IMD-SE-1)27289BETOPTIC S (int opu 1x5 ml (fľ.PE))30.3.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)